First Trust Health Care AlphaDEX Fund Rating $130.70 -1.42 (-1.07%) Closing price 09/23/2026 04:10 PM EasternExtended Trading$130.71 +0.01 (+0.01%) As of 07:37 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsSEC FilingsShort Interest First Trust Health Care AlphaDEX Fund Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FXH Aggregate RatingModerate Buy 2.60Holdings in FXH have an aggregate rating of Moderate Buy based on 495 analyst ratings issued in the past year covering 25 companies (53.9% of the portfolio).FXH Aggregate Price Target$130.70High Prediction$130.70Average Prediction$130.70Low Prediction$130.70Holdings in FXH have an aggregate price target of $130.70 and a range of $130.70 to $130.70 covering 25 companies (53.9% of the portfolio).FXH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust Health Care AlphaDEX Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 FXH Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings2.79%REGNRegeneron Pharmaceuticals$801.82-0.3%Moderate Buy$802.18 0.0%243.7165 of 5 starsAnalyst Forecast2.76%NTRANatera$390.790.0%Moderate Buy$330.83 -15.3%231.596 of 5 starsTrending News2.55%SOLVSolventum$88.31-0.5%Moderate Buy$92.80 5.1%121.5814 of 5 stars2.55%UHSUniversal Health Services$181.61+1.3%Hold$204.94 12.8%183.2575 of 5 stars2.52%PFEPfizer$28.16+0.8%Hold$28.39 0.8%212.7908 of 5 starsTrending News2.45%GHGuardant Health$176.31-0.5%Moderate Buy$188.13 6.7%262.1762 of 5 stars2.45%ZBHZimmer Biomet$91.05-3.1%Hold$103.00 13.1%224.0465 of 5 stars2.37%CNCCentene$61.97-2.1%Hold$70.05 13.0%213.9456 of 5 stars2.31%BSXBoston Scientific$44.58-0.8%Moderate Buy$70.19 57.5%314.714 of 5 starsAnalyst Forecast2.31%THCTenet Healthcare$256.23-2.2%Moderate Buy$277.25 8.2%213.9945 of 5 starsAnalyst Forecast2.30%CICigna Group$267.75-2.2%Moderate Buy$337.10 25.9%234.9141 of 5 stars2.25%HALOHalozyme Therapeutics$112.44-2.3%Moderate Buy$91.20 -18.9%133.1015 of 5 stars2.10%CORTCorcept Therapeutics$112.94-3.9%Moderate Buy$138.17 22.3%83.8661 of 5 stars2.10%GMEDGlobus Medical$73.87-1.8%Moderate Buy$101.77 37.8%174.3078 of 5 stars1.98%EHCEncompass Health$122.06-0.6%Buy$148.20 21.4%74.7481 of 5 starsPositive News1.96%MDTMedtronic$89.28-1.6%Moderate Buy$103.92 16.4%284.9628 of 5 starsTrending News1.94%AXSMAxsome Therapeutics$193.45-4.8%Moderate Buy$271.85 40.5%223.8073 of 5 starsAnalyst Forecast1.87%RMDResMed$221.99+0.0%Hold$241.69 8.9%164.0272 of 5 starsPositive News1.86%DVADaVita$183.08-0.4%Moderate Buy$233.43 27.5%74.73 of 5 stars1.81%MDLNMedline$34.30-0.4%Moderate Buy$47.42 38.3%293.0294 of 5 starsAnalyst Forecast1.79%ELVElevance Health$398.00-1.1%Moderate Buy$440.90 10.8%234.1748 of 5 stars1.76%INCYIncyte$124.64-1.8%Moderate Buy$124.05 -0.5%253.1461 of 5 starsTrending NewsAnalyst Forecast1.75%QGENQiagen$43.76+0.2%Hold$43.51 -0.6%143.638 of 5 stars1.68%ZTSZoetis$71.67-1.6%Hold$101.08 41.0%194.3948 of 5 stars1.67%DOCSDoximity$26.53+0.1%Hold$32.18 21.3%254.3767 of 5 starsTrending News This page (NYSEARCA:FXH) was last updated on 9/24/2026 by MarketBeat.com Staff. From Our PartnersEveryone remembers January's silver spike. Then what?Silver is up more than 50 percent over the past year, yet interest has faded since its January record. The ...i2i Marketing Group, LLC | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredHow to get a stake in Anthropic — before the IPOAnthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its ...Weiss Ratings | SponsoredWhile SpaceX Gets the Spotlight, FJET Is Building What Comes Next!Starfighters Space (NYSE: FJET) operates the world's only commercial fleet of flight-ready Mach 2+ F-104 Starf...Trading Wire | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | SponsoredThey're shrinking your dollars every single monthSince 2020, the dollar has lost roughly a quarter of its buying power. A $500,000 nest egg today buys about wh...American Alternative | SponsoredWhy I believe the AI market will split in Q4Matt McCall, who recommended Nvidia near $6 a share, says the AI market is splitting in two - just like the do...The Oxford Club | SponsoredShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Health Care AlphaDEX Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust Health Care AlphaDEX Fund With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
